Skip to main content

ORIGINAL RESEARCH article

Front. Immunol.
Sec. Cancer Immunity and Immunotherapy
Volume 15 - 2024 | doi: 10.3389/fimmu.2024.1474564

The cancer-associated fibroblasts interact with malignant T cells in mycosis fungoides and promote the disease progression

Provisionally accepted
YIGE ZHAO YIGE ZHAO Yong Li Yong Li Panpan Wang Panpan Wang *Mengyan Zhu Mengyan Zhu *Jiaqi Wang Jiaqi Wang Bo Xie Bo Xie *Chenyu Tang Chenyu Tang Yangyang Ma Yangyang Ma *Shiwen Wang Shiwen Wang Sha Jin Sha Jin *Jinhui Xu Jinhui Xu *Zhao Li Zhao Li *Xiaoyan Zhang Xiaoyan Zhang *Liuyu Li Liuyu Li *Xiuzu Song Xiuzu Song Ping Wang Ping Wang *
  • Hangzhou Third People's hospital, Hangzhou, China

The final, formatted version of the article will be published soon.

    Background Cutaneous T cell lymphoma (CTCL) is a heterogeneous group of T-cell lymphomas characterized with the presence of clonal malignant T cells. Mycosis fungoides (MF) is the most common type of CTCL. However, the pathogenesis of MF and the role of the tumor microenvironment (TME) remains unclear. Methods We performed single-cell RNA sequencing on tumor & adjacent normal tissues and peripheral blood mononuclear cell (PBMC) from advanced MF patients and healthy control (HC). We compared skin lesions in different stages within the same patient to overcome inter-individual variability. Results The malignant clones displayed dual phenotypes characterized with tissue resident memory T cells (TRMs) and central memory T cells (TCMs). We supposed that the tumor cells transformed from TRM dominant phenotype to TCM dominant phenotype during MF progressed from early-stage to advanced-stage. The cancer-associated fibroblasts (CAFs) showed active role in TME. The occurrence of inflammatory CAFs (iCAFs) may represent the advanced-stage MF. There may be mutual positive feedback of the crosstalk between tumor cells and CAFs during the MF development. Tumor cells promote CAFs generation and the CAFs, in turn, improve the invasiveness and metastasis of the malignant T cells through the IL-6/JAK2/STAT3/SOX4 or IL-6/HIF-1α/SOX4 pathway. SOX4 may be a critical regulatory gene of this positive feedback loop. Target SOX4 may disrupt the interactions between tumor cells and CAFs. Conclusion Our study revealed the origin and evolution trajectory of MF, uncovered the intercellular interactions between malignant T cells and CAFs, providing new insights into the novel treatment targets of MF.

    Keywords: Mycosis fungoides (MF), Cutaneous T cell lymphoma (CTCL), Tissue resident memory T cell (TRM), Cancer-associated fibroblast (CAF), Tumor Microenvironment, Sox4

    Received: 01 Aug 2024; Accepted: 31 Dec 2024.

    Copyright: © 2024 ZHAO, Li, Wang, Zhu, Wang, Xie, Tang, Ma, Wang, Jin, Xu, Li, Zhang, Li, Song and Wang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence:
    Panpan Wang, Hangzhou Third People's hospital, Hangzhou, China
    Mengyan Zhu, Hangzhou Third People's hospital, Hangzhou, China
    Bo Xie, Hangzhou Third People's hospital, Hangzhou, China
    Yangyang Ma, Hangzhou Third People's hospital, Hangzhou, China
    Sha Jin, Hangzhou Third People's hospital, Hangzhou, China
    Jinhui Xu, Hangzhou Third People's hospital, Hangzhou, China
    Zhao Li, Hangzhou Third People's hospital, Hangzhou, China
    Xiaoyan Zhang, Hangzhou Third People's hospital, Hangzhou, China
    Liuyu Li, Hangzhou Third People's hospital, Hangzhou, China
    Ping Wang, Hangzhou Third People's hospital, Hangzhou, China

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.